2-amino-4-chloro-N,N-dimethylbenzamide, 95.0%, 1g

6-Bromo-2-methoxynicotinaldehyde, 95.0%, 500mg

ethyl cyclopropyl(oxo)acetate, 95.0%, 1g

2,8-Dichloro-7-methylquinoline, 97%, 250mg

Imidazo[1,2-a]pyridin-7-amine dihydrochloride, 96%, 250mg

3-Phenylquinazolin-4(3H)-one, 98.0%, 5g

2-Bromo-5-(hydroxymethyl)benzoic acid, 95%, 1g

3-Benzyloxypropyl(triphenyl)phosphonium bromide, 98+%, 250mg

3,5-Bis-methylsulfanyl-isothiazole-4-carboxylic acid, 95.0%, 250mg

Isobutyric acid, >=99%, for synthesis, 2.5 L, glass packaging

ROTI®Pol TaqHY, 500 µl, 5 x 500 U

3-Amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one, 95.0%, 1g

Methyl 3-mercaptobenzoate, 95%, 1g